EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Albumin‐Photosensitizer Supramolecular Assembly with Type I ROS‐Induced Multifaceted Tumor Cell Deaths for Photodynamic Immunotherapy

Jingtian Zhang, Di Jiao, Xinwen Qi, Yufan Zhang, Xiaoang Liu, Tengwu Pan, Heqi Gao, Zhaoyun Liu, Dan Ding iD, Guangxue Feng

Advanced Science · 2025-03 · 12 (9)

DOI: 10.1002/advs.202410405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 13.01.2025. Verfasst von Jingtian Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Frontiers Science Center for Cell Responses, State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials, Ministry of E…. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Reactive Oxygen Species, Immunotherapy. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Tianjin Postgraduate Research Innovation Project, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy holds great potentials in cancer treatment, yet its effectiveness in hypoxic solid tumor is limited by the oxygen‐dependence and insufficient oxidative potential of conventional type II reactive oxygen species (ROS). Herein, the study reports a supramolecular photosensitizer, BSA@TPE‐BT‐SCT NPs, through encapsulating aggregation‐enhanced emission photosensitizer by bovine serum albumin (BSA) to significantly enhance ROS, particularly less oxygen‐dependent type I ROS for photodynamic immunotherapy. The abundant type I ROS generated by BSA@TPE‐BT‐SCT NPs induce multiple forms of programmed cell death, including apoptosis, pyroptosis, and ferroptosis. These multifaceted cell deaths synergistically facilitate the release of damage‐associated molecular patterns and antitumor cytokines, thereby provoking robust antitumor immunity. Both in vitro and in vivo experiments confirmed that BSA@TPE‐BT‐SCT NPs elicited the immunogenic cell death, enhance dendritic cell maturation, activate T cell, and reduce myeloid‐derived suppressor cells, leading to the inhibition of both primary and distant tumors. Additionally, BSA@TPE‐BT‐SCP NPs also exhibited excellent antitumor performance in a humanized mice model, evidenced by a reduction in senescent T cells among these activated T cells. The findings advance the development of robust type I photosensitizers and unveil the important role of type I ROS in enhancing multifaceted tumor cell deaths and antitumor immunogenicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyPhotosensitizing AgentsReactive Oxygen SpeciesImmunotherapySerum Albumin, BovineNeoplasmsAnimalsMiceHumansApoptosisCell Line, TumorNanoparticles

Stichwörter der Autor:innen

Type I photodynamic therapyferroptosisimmunogenic cell deathprogrammed cell deathpyroptosis

Substanzen

Photosensitizing AgentsReactive Oxygen SpeciesSerum Albumin, Bovine

Autor:innen und Institutionen

  • Frontiers Science Center for Cell Responses, State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials, Ministry of Education, and College of Life Sciences, Nankai University, Tianjin, 30…
  • Department of Hematology, Tianjin Medical University General Hospital, Tianjin Key Laboratory of Bone Marrow Failure and Malignant Hemopoietic Clone Control, Tianjin Institute of Hematology, Tianjin, 300052, China.
  • Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates, State Key Laboratory of Luminescent Materials and Devices, School of Materials Science and Engineering, AIE Institute, South China Universit…

ORCID-Profile: Dan Ding

Förderung

  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • Tianjin Postgraduate Research Innovation Project, China Postdoctoral Science Foundation
  • Tianjin Key Medical Discipline(Specialty) Construction project
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Science Fund for Distinguished Young Scholars of Tianjin Municipality
  • Key Research and Development Program of Hunan Province of China

Zitieren

APA

Zhang, J., Jiao, D., Qi, X., Zhang, Y., Liu, X., Pan, T., Gao, H., Liu, Z., Ding, D., & Feng, G. (2025). An Albumin‐Photosensitizer Supramolecular Assembly with Type I ROS‐Induced Multifaceted Tumor Cell Deaths for Photodynamic Immunotherapy. Advanced Science, 12(9). https://doi.org/10.1002/advs.202410405

Vancouver

Zhang J, Jiao D, Qi X, Zhang Y, Liu X, Pan T, et al. An Albumin‐Photosensitizer Supramolecular Assembly with Type I ROS‐Induced Multifaceted Tumor Cell Deaths for Photodynamic Immunotherapy. Advanced Science. 2025;12(9). doi:10.1002/advs.202410405

BibTeX
@article{Zhang2025,
  author = {Zhang, Jingtian and Jiao, Di and Qi, Xinwen and Zhang, Yufan and Liu, Xiaoang and Pan, Tengwu and Gao, Heqi and Liu, Zhaoyun and Ding, Dan and Feng, Guangxue},
  title = {An Albumin‐Photosensitizer Supramolecular Assembly with Type I ROS‐Induced Multifaceted Tumor Cell Deaths for Photodynamic Immunotherapy},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {9},
  doi = {10.1002/advs.202410405}
}
Kostenlos starten →